Literature DB >> 12071514

Volumetric brain imaging findings in mood disorders.

John L Beyer1, K Ranga R Krishnan.   

Abstract

Volumetric neuroimaging is increasingly being used by researchers of affective disorders to assess potential involvement of different brain structures in mood regulation and to test neuroanatomic models of mood disorders. In unipolar depression, findings suggest abnormalities in the frontal lobe (particularly the subgenual prefrontal cortex), basal ganglia (particularly the caudate and putamen), cerebellum, and hippocampus/amygdala complex. In bipolar disorder, abnormalities in the third ventricle, frontal lobe, cerebellum, and possibly the temporal lobe are noted. We review the findings for the various regions of the brain, and discuss the implications on the understanding of mood disorders. Directions for future research in volumetric imaging is then discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12071514     DOI: 10.1034/j.1399-5618.2002.01157.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  49 in total

1.  Effects of neonatal flutamide treatment on hippocampal neurogenesis and synaptogenesis correlate with depression-like behaviors in preadolescent male rats.

Authors:  J M Zhang; L Tonelli; W T Regenold; M M McCarthy
Journal:  Neuroscience       Date:  2010-04-21       Impact factor: 3.590

2.  A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder.

Authors:  Ralf Brisch; Hans-Gert Bernstein; Henrik Dobrowolny; Dieter Krell; Renate Stauch; Kurt Trübner; Johann Steiner; Mounir N Ghabriel; Hendrik Bielau; Rainer Wolf; Jana Winter; Siegfried Kropf; Tomasz Gos; Bernhard Bogerts
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-07-07       Impact factor: 5.270

3.  Managing bipolar disorder from urgent situations to maintenance therapy.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

4.  Neocortical gray matter volume in first-episode schizophrenia and first-episode affective psychosis: a cross-sectional and longitudinal MRI study.

Authors:  Motoaki Nakamura; Dean F Salisbury; Yoshio Hirayasu; Sylvain Bouix; Kilian M Pohl; Takeshi Yoshida; Min-Seong Koo; Martha E Shenton; Robert W McCarley
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

Review 5.  Volumetric brain imaging studies in the elderly with mood disorders.

Authors:  John L Beyer
Journal:  Curr Psychiatry Rep       Date:  2006-02       Impact factor: 5.285

6.  Association analysis of the COMT/MTHFR genes and geriatric depression: an MRI study of the putamen.

Authors:  Chih-Chuan Pan; Douglas R McQuoid; Warren D Taylor; Martha E Payne; Allison Ashley-Koch; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2009-08       Impact factor: 3.485

7.  Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.

Authors:  P E Adams; J S Adams; D V Nguyen; D Hessl; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C Decarli; P J Hagerman; R J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

8.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

Review 9.  Defining the human hippocampus in cerebral magnetic resonance images--an overview of current segmentation protocols.

Authors:  C Konrad; T Ukas; C Nebel; V Arolt; A W Toga; K L Narr
Journal:  Neuroimage       Date:  2009-05-15       Impact factor: 6.556

Review 10.  Brain imaging and psychotherapy: methodological considerations and practical implications.

Authors:  David E J Linden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-11       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.